Valuation
- Market cap
- 24,489,000
- Revenue TTM
- $0
- Net income TTM
- $-21,020,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 804,100
- Avg volume
- 450,376
- Day's range
- $0.42 – $0.45
- Shares out
- 56,349,000
- Stochastic %K
- 80%
- Beta
- -0.76
- Analysts
- Sell
- Price target
- $3.50
Company profile
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnost...
Show more
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.
- Industry
- Health Information Services
- Sector
- Healthcare
- Phone
- 408 899 4443
- Website
- https://www.heartbeam.com
- Address
- 2118 Walsh Avenue, Suite 210, Santa Clara, United States
Latest news
No headlines yet.
